NOD2 and head and neck squamous cell carcinoma: In our previous study, we screened six PRGs, including IL-6, NLRP1, NLRP2, NLRP3, NOD2, and PLCG1, further demonstrating the importance of PRGs in predicting HNSCC patient outcomes [33].